Marion E. Broome, PhD, RN, FAAN, is dean and Ruby Wilson Professor of Nursing at the Duke University School of Nursing, Vice Chancellor for Nursing Affairs at Duke University, and Associate Vice President for Academic Affairs for Nursing at Duke University Health System. Prior to joining Duke, Broome was dean of the Indiana University School of Nursing, where she was awarded the rank of Distinguished Professor.

Widely regarded as an expert, scholar and leader in pediatric nursing research and practice, Broome has been funded externally by the American Cancer Society and the National Institutes of Health (NIH), as well as private foundations for more than 15 years to conduct research in which she developed and tested interventions designed to assist children to cope with acute and chronic pain. In 2000, Broome extended her research into the area of research ethics related to informed consent and assent for children in research, research misconduct in clinical trials and, most recently, ethical dilemmas in publishing. Her research is published in more than 100 papers in 50 refereed nursing, medicine and interdisciplinary journals. She also has published five books and 15 chapters in books and consumer publications.

Broome served a four-year term as an appointed member of the Nursing Science Study Section at the NIH, from 2008 to 2012. Prior to that time she served as a permanent member of Study Section in the Center for Scientific Review at NIH. Broome also has served as president of the Society for Pediatric Nurses and has been on the boards of the Association for the Care of Children's Health and the Midwest Nursing Research Society. Currently, Broome is editor-in-chief of Nursing Outlook, the official journal of the American Academy of Nursing (AAN) and the Council for the Advancement of Nursing Science. Broome has been a Fellow of the American Academy of Nursing since 1994. She was inducted into the Sigma Theta Tau International Researcher Hall of Fame in 2010. Selected honors include Outstanding Alumnus for Georgia Health Sciences University and the University of South Carolina. In 2012, she was selected to receive the National League of Nursing Award for Outstanding Leadership in Nursing Education. In 2014, she was awarded the President’s Medal for Excellence at Indiana University.

Broome currently consults with a variety of schools of nursing and Magnet-designated hospitals related to evidence-based practice programs, research implementation and professional development programs for nurses and faculty. In June 2014, the Friends of the National Institute of Nursing Research (FNINR) named Broome as one of 12 nursing leaders nationwide for the inaugural FNINR Ambassadors for Scientific Advancement Program.

Broome earned her BSN degree from the Medical College of Georgia, her MSN from the University of South Carolina and her PhD from the University of Georgia.

Jeffrey Ferranti, MD, MS, is the Senior Vice President and Chief Digital Officer.

Ferranti is responsible for leading a team charged with the visioning, strategic planning, and effective adoption of integrated technology and information solutions that enable high-quality clinical care, research and education. He also serves as an informatics thought leader, both internal and external to Duke, and, in partnership with our wider medical community, develops an overarching informatics strategy in support of the Duke Health mission.

As the leader of Duke's enterprise-wide Epic installation, he was responsible for deploying a single, seamless electronic health record across three hospitals and over 300 ambulatory clinics. Ferranti is passionate about leveraging advanced analytics to improve population health, implementing novel technologies to better partner with patients and promoting IT innovation to support new and emerging care models.

An active informatics researcher, Ferranti was the Duke principal investigator on two Agency for Healthcare Research and Quality (AHRQ)-funded research projects. The first aimed at developing a model pediatric electronic health record format, and the second evaluating the use of technology to detect and prevent adverse drug events across Duke University Health System. In addition, he ran an innovations project exploring the novel use of iPad and tablet technology in the pediatric critical care. He developed several innovative applications including the Duke Enterprise Data Unified Content Explorer (DEDUCE) and the Duke Integrated Subject Cohort Enrollment Research Network (DISCERN). Both of these projects aim to empower investigators with simple yet secure access to our enterprise data stores.

Ferranti holds a master’s degree in Biomedical Engineering and Medical Informatics from the Duke Pratt School of Engineering. He is a Six Sigma Master Black Belt and is actively involved in numerous patient safety and quality improvement projects across the health system. He is also a practicing neonatologist at Duke University Hospital.

Thomas M. Coffman, MD, is the dean for Duke-NUS Medical School. Coffman is also the James R. Clapp Professor of Medicine at Duke University Medical Center.

Coffman graduated from the University of Pennsylvania and obtained his MD from the Ohio State University School of Medicine. He undertook his internal medicine and nephrology training at Duke. A national leader in the field of nephrology, Coffman is a past president of the American Society of Nephrology, a member of the American Society for Clinical Investigation and the Association of American Physicians, and has served on the Nephrology Subspecialty Board of the American Board of Internal Medicine.

Michael H. Merson, M.D., is founding director of Duke Global Health Institute and the Wolfgang Joklik Professor of Global Health at Duke University. He joined the Duke faculty in November 2006. Merson was named Vice Chancellor for Duke-National University of Singapore (NUS) Affairs in March 2010. Most recently, Merson was named the Vice President and Vice Provost of Global Affairs at Duke University in June 2011.

Merson graduated from Amherst College (BA) and the State University of New York, Downstate Medical Center. After serving as a medical intern and resident at Johns Hopkins Hospital in Baltimore, Maryland, he worked in the Enteric Diseases Branch at the Centers for Disease Control in Atlanta, GA and then served as the Chief Epidemiologist at the Cholera Research Laboratory in Dhaka, Bangladesh. His research focused on the etiology and epidemiology of acute diarrheal diseases, including cholera, in developing countries and on the cause of travelers’ diarrhea in persons visiting these countries.

In 1978, he joined the World Health Organization (WHO) as a Medical Officer in the Diarrheal Diseases Control Program. He served as director of that program from January 1980 until May 1990. In August 1987, he was also appointed Director of the WHO Acute Respiratory Infections Control Program. In May 1990, he was appointed as Director of the WHO Global Program on AIDS. This program was operational worldwide and responsible for mobilizing and coordinating the global response to the HIV/AIDS pandemic.

In April 1995, he joined Yale University School of Medicine as its first Dean of Public Health and as Professor and Chairman of the Department of Epidemiology and Public Health, positions he held until December 2004. In 2001, he was named as the Anna M. R. Lauder Professor of Public Health in the Yale University School of Medicine. From 1999 to 2006, he also served as Director of the Center for Interdisciplinary Research on AIDS at Yale University, which undertakes research on HIV prevention in vulnerable and underserved populations in this country and abroad. He also led a number of training programs that strengthened the capacity of scientists in Russia, China, India and South Africa to undertake HIV/AIDS prevention research.

Merson has authored more than 175 articles, primarily in the area of disease prevention. His most recent contributions concern HIV policy and prevention in developing countries and broader global health issues. He is the senior editor of Global Health: Disease, Programs, Systems, and Policies, which is a leading global health textbook in the United States.

He has served in advisory capacities for UNAIDS, WHO, the Global Fund to Fight AIDS, TB and Malaria, World Bank, Doris Duke Foundation, World Economic Forum, and the Bill & Melinda Gates Foundation, and on several NIH review panels and advisory committees. He is a member of the Commission for Smart Global Health Policy at the Center for Strategic and International Studies.

Merson has received two Commendation Medals from the U.S. Public Health Service, the Arthur S. Flemming Award for distinguished government service, the Surgeon General’s Exemplary Service Medal and two honorary degrees and is an elected member of the Institute of Medicine in the National Academy of Sciences.

Chris Beyrer, MD, MPH, an internationally recognized epidemiologist who has worked on the front lines of HIV/AIDS and COVID-19 treatment and research, is the director of the Duke Global Health Institute.

Beyrer, who has worked on COVID-19 vaccine trials since 2020, currently serves as senior scientific liaison to the COVID-19 Vaccine Prevention Network. He is past president of the International AIDS Society, the world’s largest body of HIV professionals and has served as advisor to the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), the HIV Vaccine Trials Network, the National Institutes of Health’s Office of AIDS Research, the U.S. Military HIV Research Program, the World Bank, the World Health Organization, and the Open Society Foundations, among numerous other organizations. The author of “War in the Blood: Sex, Politics and AIDS in Southeast Asia,” he has conducted collaborative research in Thailand for 30 years.

Before coming to Duke, Beyrer was the inaugural Desmond M. Tutu Professor of Public Health and Human Rights at the Johns Hopkins Bloomberg School of Public Health, where he also was a professor of epidemiology, international health, nursing and medicine. At Johns Hopkins, he directed the T32 Training Program in HIV Epidemiology and Prevention Science and served as associate director of the JHU Center for AIDS Research and the Center for Global Health. He was the founding director of the Center for Public Health and Human Rights.

Beyrer received his medical degree from SUNY Downstate Health Sciences University and holds a Master of Public Health from Johns Hopkins Bloomberg School of Public Health. He was elected to the National Academy of Medicine in 2014 and serves on the Academy’s Board for Global Health, and on the Committee for Human Rights.

Megan Haymaker joined Duke Raleigh Hospital, a Campus of Duke University Hospital as Chief Human Resources Officer in August, 2022. Haymaker brings more than 15 years of healthcare experience to the team, and comes to us from Indiana University (IU) Health, where she most recently served as Vice President of Human Resources, East Central Region.

In her role, Haymaker held responsibility for 3 hospitals and 3,000 team members, as well as an employee physician group. Some significant successes under her leadership include leading member engagement and retention, and diversity and inclusion initiatives. Her region was recognized as 2022 LGBTQ+ Healthcare Equality Leader by the Human Rights Campaign Foundation, and also expanded diversity recruitment efforts to include international nurses, Afghan refugees, and intentional outreach to universities and community organizations.

Haymaker has led organizational projects and participated in key strategic initiatives, including serving as an HR lead for the IU Health system COVID-19 response, as well as previous leadership experience in talent acquisition and compensation.

Haymaker is a tremendous asset to the Duke Raleigh team, and is passionate about growing our teams, and nurturing the professional development of our staff.

Dr. Ted Boyse, MD, is the Chief Medical Officer for Duke Raleigh Hospital, a Campus of Duke University Hospital. He was appointed as chief in July, 2022. Prior to this, Dr. Boyse served as Associate Chief Medical Officer for one year.

Over the past 18 years, Dr. Boyse has made important and varied contributions to Duke Health System. He has held multiple leadership roles at Duke Raleigh Hospital, including eleven years as part of the hospital’s medical executive committee, holding the roles of department chair, president elect, and president.

Dr. Boyse is known and recognized for his commitment to valuing and developing people while creating effective care environments through process improvements. He brings unique insight into how Duke Raleigh can best grow and support its medical staff, expand services, and further Duke Health’s commitment to delivering the best patient care.

Dr. Boyse earned his medical degree from Vanderbilt University School of Medicine in Nashville, completed his Radiology Residency at the University of Michigan and his Musculoskeletal Radiology Fellowship at the Mallinckrodt Institute of Radiology in St. Louis.

Ian Lee Brown is the Vice-President and Chief Employee Experience Officer at Duke University Health System.

In his role, Brown leads the organization’s diversity, equity, inclusion and belonging strategy and well-being and workplace safety initiatives. He ensures these elements are embedded within the system’s culture, so employees can live their authentic selves and deliver exceptional care to our diverse population of patients.

Prior to this role, Brown served in various senior-level roles in national healthcare, senior living and educational organizations, leading culture, diversity, talent, community outreach and operations. In these roles he had responsibility for leading over 1,200 employees and managing budgets in excess of $200 million.

Brown has served as a board member for numerous charitable organizations whose missions have included higher education, advocacy for the older adult population, including LGBTQ+ elders, youth, healthcare, affordable housing and hunger.

Brown completed undergraduate studies at Brooklyn College in New York City. He earned a Master of Arts in Liberal Studies at Chicago’s Lake Forest College and both a Master of Science in Applied Behavioral Science/Organizational Development and Graduate Certificate in Senior Housing and Healthcare from the Johns Hopkins University Carey Business School in Baltimore. At Hopkins, he also spent a year in the Mid-Atlantic Health Leadership Institute at the Bloomberg School of Public Health.

Mike Datto, MD, PhD is an AP/CP/MGP board-certified pathologist, vice chair of clinical pathology for the department of pathology at Duke University and the medical director and associate vice president for Duke University Health System Clinical Laboratories. In his role as associate vice president, Datto is responsible for maintaining the standards of the College of American Pathologists and CLIA/CMS within all clinical laboratories at Duke. 

Specifically, Datto oversees clinical testing; develops quality management systems and proficiency testing programs; provides consultation with ordering physicians; develops strategic plans in line with patient, physician and health system leadership needs; coordinates research and development; ensures adequate and appropriately trained personnel; and provides profession interpretation for molecular diagnostic testing including the wide range of PCR, quantitative PCR, sequencing, NGS and FISH based tests for inherited genetic diseases, hematologic malignancies, solid tumors and infectious diseases.

In the past, Datto worked in the Lab of Xiao-Fan Wang, defining the mechanisms by which transforming growth factor beta exerts its cellular actions in health and disease. Following the completion of medical school, Datto trained as a resident in pathology at Duke. He has been on faculty in the department of pathology ever since.

Outside of Duke, Datto has served on many national committees as a leader in laboratory medicine, including service to the College of American Pathologists as the Chair of the Accreditation Committee, and overseeing the accreditation decisions for all CAP accredited laboratories.

Datto received a BA from Johns Hopkins University in Biology. He went on to receive his MD and PhD from Duke University as part of the Medical Scientists Training Program.

Richard P. Shannon, MD serves as the Senior Vice President and Chief Medical Officer for Duke University Health System. In this role, Shannon works in partnership with our Nurse, Physician and Administrator triads to oversee governance, strategy and operational outcomes for our comprehensive centers of excellence, including Neurosciences, Heart, Oncology and Musculoskeletal.

As Chief Quality Officer for Duke Health, Shannon is responsible for the overall direction, leadership and operational management of the quality and safety programs of Duke Health, and provides leadership in strengthening a quality culture where everyone is engaged and respected.

Shannon received his BA from Princeton University and his MD from the University of Connecticut School of Medicine. He completed his training in internal medicine at Beth Israel Hospital, his cardiovascular training at Massachusetts General Hospital, and was the Francis Weld Peabody Fellow and Associate Professor of Medicine at Harvard Medical School before becoming the Claude R. Joyner Professor of Medicine at Drexel University College of Medicine.

Prior to joining Duke Health, he served as executive vice president for health affairs at the University of Virginia, where he worked with faculty and staff to transform the UVA Health System into the premier health care provider in Virginia. Shannon has also served as the Frank Wister Thomas Professor and Chair of the Department of Medicine at the University of Pennsylvania Perelman School of Medicine, and as Chair of the Department of Medicine at Allegheny General Hospital in Pittsburgh. Shannon has received numerous teaching awards from Harvard Medical School, Drexel University College of Medicine and the University of Pennsylvania School of Medicine.

Shannon’s investigative interests are in the areas of myocardial metabolism and heart failure, specifically the role of energetics in the progression of heart failure. Shannon’s lab was the first to discover the beneficial CV actions of incretins which formed the basis for Ventrigen, LLC, a company designed to develop incretins for the use in treating heart failure.

Shannon's pioneering work in patient safety is chronicled in the chapter “First, Do No Harm” in Charles Kenney’s The Best Practice - How the New Quality Movement is Transforming Medicine. His innovative work also has been featured in The Wall Street Journal and The New York Times, on CNN and CNBC news segments, and on ABC's "20/20", and was a centerpiece for the PBS report entitled "Remaking American Medicine." 

Shannon is an elected member of honorary organizations, including the American Society for Clinical Investigation, and served as a senior fellow of the Leonard Davis Institute of Health Economics at the University of Pennsylvania. He currently is a teaching fellow for the Institute of Healthcare Improvement. He is a Director of the National Institutes of Health, Clinical Center Research Hospital Board; and a member of the Boards of Directors of the Kaiser Foundation Hospitals and Kaiser Foundation Health Plan, Inc., where he chairs the Quality Health Improvement Committee.